The pharmaceutical industry is unlike any other industry in that the products manufactured can dramatically improve, and even save, lives. This is especially the case when it comes to children. Although pediatric patients comprise a smaller population of pharmaceutical consumers, they have a greater need for products given the paucity of treatment options specifically for them. This two-part paper discusses the need for collaboration across the industry to ensure children get the medicines they need. Download to read Part One or click here to read Part Two.
Collaboration Advances Small Pharma Company’s Pediatric Development Plan to First-in-Pediatrics RSV Study
A Phase II, randomized, double-blind, placebo-controlled, 2-part study to evaluate the safety, tolerability, pharmacokinetics, clinical response, and…
The Center for Pediatric Clinical Development
We’re driving pediatric clinical research forward and protecting kids through research, not from it.
Arjen Akkerman, Senior Director of Chemistry Manufacturing Control (CMC)
We measure our HQ with actions, experiences, and intentions. Nowhere is that more evident that in the stories of our subject matter experts. We want…